Appointments

Bayer appoints Sarena Lin as Chief Transformation and Talent Officer

She will serve as Labor Director.

  • By ICN Group | January 12, 2021

The Supervisory Board of Bayer AG announced the appointment of Sarena Lin to the company’s Board of Management as of February 1, 2021. Lin will become the company’s Chief Transformation and Talent Officer. She will be responsible for Human Resources, Strategy and Business Consulting and drive the accelerated transformation of Bayer. Additionally, she will serve as Labor Director.

 

Lin will be based at the company’s headquarters in Leverkusen, Germany. She will join Bayer from Elanco Animal Health Incorporated, where she is a member of the Executive Committee, responsible for the areas of Transformation and Technology. She previously worked in senior positions at McKinsey and Cargill, among others. Lin holds citizenship from the United States of America and Taiwan. She speaks English, Mandarin Chinese and basic German.

 

 “We are delighted that Sarena Lin will strengthen the Bayer Board of Management with her global experience, strategic expertise, leadership skills and ability to lead large-scale transformations,” said Norbert Winkeljohann, Chairman of the Supervisory Board of Bayer AG. “Bayer must now decisively accelerate the transformation it has initiated. Few companies have the potential to benefit from the ongoing bio revolution as much as Bayer. The company’s leading positions in attractive life science businesses must be translated into accelerated growth and value creation.”

 

 “The employee representatives on the Supervisory Board welcome the appointment of Sarena Lin as a member of the Board of Management – and thus also the appointment of a woman as Labor Director. Based on her international experience and expertise, she will provide fresh impetus. We expect our dialogue on future HR policy and the development of our work culture here at Bayer to be conducted in a spirit of trust – guided by the social partnership we have actively promoted here for so long,” said Oliver Zühlke, Deputy Chairman of Bayer’s Supervisory Board.

Upcoming Conferences

More from Appointments

Startup

Chemical

Petrochemical

Digitization

Gas